Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 38,213 | 37,200 | 38,903 | 40,781 | 32,810 |
| Cost of Goods | 11,914 | 9,857 | 8,457 | 10,228 | 9,458 |
| Gross Profit | 26,299 | 27,343 | 30,446 | 30,553 | 23,352 |
| Operating Expenses | 31,306 | 29,837 | 27,749 | 26,608 | 28,268 |
| Operating Income | -4,093 | -1,637 | 3,154 | 4,173 | -4,458 |
| Other Income | -13,402 | -744 | -519 | -510 | -390 |
| Pre-tax Income | -17,495 | -2,381 | 2,635 | 3,663 | -4,848 |
| Net Income Continuous | -17,495 | -2,381 | 2,635 | 3,663 | -4,848 |
| Net Income | $-17,495 | $-2,381 | $2,635 | $3,663 | $-4,848 |
| EPS Basic Total Ops | -0.10 | -0.02 | 0.02 | 0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.10 | -0.02 | 0.02 | 0.02 | -0.03 |
| EPS Diluted Total Ops | -0.10 | -0.02 | 0.01 | 0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.10 | -0.02 | 0.01 | 0.02 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.02 | 0.01 | 0.02 | -0.03 |
| EBITDA(a) | $-3,932 | $-539 | $3,635 | $4,665 | $-5,254 |